article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

article thumbnail

Study: Potential Adverse Drug Events When Combining THC with Other Medication

The Joint Blog

And with the legalization of cannabis in Canada and legislation in 33 US states allowing for some kind of marijuana use (recreational or medicinal), the popularity of cannabis has been on the rise. Reported adverse effect in many clinical trials included amnesia, impaired balance, disturbed attention, dizziness, lethargy, and somnolence.

Events 48
article thumbnail

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Cannabis Law Report

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

article thumbnail

Prohibition (UK) Publish…. PSYCH: THE PSYCHEDELICS AS MEDICINE REPORT

Cannabis Law Report

KEY FINDINGS FROM THE REPORT INCLUDE: While cannabis has already paved much of the way for psychedelics in terms of legal progress and changing public perception, psychedelics as medicines are already backed by a more powerful knowledge base comparatively. Unsurprisingly the event follows in June.

article thumbnail

FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals

Cannabis Law Report

Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.